loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Somatropin (ATC: H01AC01) im Rahmen eines sogenannten Open-House-Modells.

World Biggest Tenders Source

This tender with title Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Somatropin (ATC: H01AC01) im Rahmen eines sogenannten Open-House-Modells. has been published on Bidding Source portal dated 15 May 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Somatropin (ATC: H01AC01) im Rahmen eines sogenannten Open-House-Modells.
Contract notice
2019/S 092-221720
Germany
Germany-Eisenberg
15 May 2019
30 Apr 2021
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient tafluprost (S01EE05) as part of a so-called open house model. - 223961-2024 Germany Pharmaceutical products – Open house drug discount agreements Dronedarone, ATC C01BD07 - 223645-2024 Germany Pharmaceutical products – Open house drug discount agreements Lamivudine, tenofovir disoproxil and doravirine, ATC J05AR24 - 226187-2024 Germany Pharmaceutical products – Open house drug discount agreements Alitretinoin, ATC D11AH04 - 225084-2024 Germany Pharmaceutical products – Open house drug discount agreements oxycodone and naloxone, ATC N02AA55 - 224231-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient ciclosporin (S01XA18) as part of a so-called open house model. - 224543-2024 Germany Pharmaceutical products – Open house drug discount agreements Calcipotriol and Betamethasone, excluding ointments, ATC D05AX22 - 226938-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient melatonin (N05CH01), excluding prolonged-release tablets with an effective strength of 2mg as part of a so-called open-house model. - 224643-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredients timolol and brinzolamide (S01ED67) as part of a so-called open house model. - 223838-2024 Germany Pharmaceutical products – Open house drug discount agreements Interferon beta-1a, finished drug name Avonex, ATC L03AB07 - 224063-2024 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans